Acadia pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that on october 4, 2023, the compensation committee of acadia's board of directors (the “committee”) granted inducement awards consisting of non-qualified stock options to purchase 145,119 shares of common stock and 38,559 restricted stock units (“rsus”) to 19 new employees under acadia's 2023 inducement plan. the compensation committee approved the awards as an inducement material to the new employees' emplo.
ACAD Ratings Summary
ACAD Quant Ranking